Search Results 2081-2090 of 21686 for platelets

1. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   Platelets count ≥ 100x10E9/L; Serum alkaline phosphatase ≤ 3x ULN (upper limit of normal)in the absence of liver or bone metastases or ≤5 ULN(in patients ...

2. A Study to Find the Recommended Dose for Further Research for VX-970 and Whole Brain Radiation Therapy to Treat Patients with Brain Metastases from Non-Small Cell Lung Cancer - Mayo Clinic

   Platelets >= 100,000/mcL; If no known liver metastases: total bilirubin < 1.5 x institutional upper limit of normal (ULN); if known liver metastases, then ...

3. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   Platelet count ≥ 75 × 10^3/μL without transfusion in the past 2 weeks;; ALT, AST, or GGT ≤ 2.5 × the upper limit of normal (ULN) if there is no liver ...

4. Testing Olaparib For One Or Two Years, With Or Without Bevacizumab, To Treat Ovarian Cancer - Mayo Clinic

   Platelets ≥ 100,000 cells/mm^3. Hemoglobin ≥ 9 g/dl. Creatinine clearance (CrCL) of > 30 mL/min by the Cockcroft-Gault formula. Total bilirubin ≤ 1.5 x ...

5. Study to Assess the Safety of the Temporarily Implanted Nitinol Device Compared to the Urolift® System in Subjects With Symptomatic Benign Prostatic Hyperplasia - Mayo Clinic

   Taking anti-platelet or anticoagulants (except low dose aspirin - 81 mg - 100 mg) within the last 7 days prior to randomization; Known or suspected allergy ...

6. Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

   Platelets ≥ 100 x 10^9/L (100 x 10^9/L is equivalent to 100 x 10^3/μL and 100 x K/μL and 100 x 10^3/cumm and 100,000/μL);; Hemoglobin ≥ 9 g/dL (9 g/dL is ...

7. HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers - Mayo Clinic

   - Platelets ≥ 75,000 cells/mm^3 (within 8 weeks of registration) - Absolute neutrophil count > 1500 cells/mm^3 (within 8 weeks of registration)

8. A Study to Assess Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer - Mayo Clinic

   Platelet count ≥ 75,000/mm^3;; Creatinine ≤ 1.4 mg/dL;; Total bilirubin ≤ 3.0 mg/dL;; Aspartate transaminase (AST) ≤ x upper limit of normal (ULN);; Alanine ...

9. A Study of Ibubilast in Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

   eosinophilia (absolute eosinophil count of ≥ 500 eosinophils per microliter), low platelet counts (< 150 x 109 per liter), alanine aminotransferase (ALT) ...

10. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    ... platelet donation within 90 days prior to screening * History of severe allergic reaction to a biologic agent * Active suicidal ideation within 6 months ...